Back to results
US 2025/0042587 A1Published application
Topical formulations and methods for bioactive & bioavailable naringenin for treating skin conditions
AssigneeProtocol Lab, LLC
InventorTyler Thomas Gaul
Life of this patent
Estimating the term…
Abstract
A method for treating a skin condition in a human patient. The method includes applying, to one or more affected areas of the human patient's skin, a naringenin formulation having an amount of naringenin effective to reduce or inhibit inflammatory processes.
Claims20
A method for treating a skin condition in a human patient, the method comprising:
- applying, to one or more affected areas of the human patient's skin, a naringenin formulation having an amount of naringenin effective to reduce or inhibit inflammatory processes.
A method of packaging a skin treatment product for widespread consumer treatment, the method comprising:
- providing an oxygen-free packaging environment;
- providing one or more product packages within the oxygen-free packing environment, the one or more product packages being substantially non-gas permeable;
- within the oxygen-free packing environment, substantially filling the one or more product packages with a naringenin formulation;
- and
- sealing the one or more product packages so as to be substantially non-gas permeable.
2 more elements
A packaged treatment for treating a skin condition in a human patient, the packaged treatment comprising:
- a product package that is substantially non-gas permeable;
- and
- a naringenin formulation disposed within the product package,
- wherein the naringenin formula was disposed within the product package within an oxygen-free environment.
1 more element
Dependencies are inferred from the claim text.